197 related articles for article (PubMed ID: 28318610)
1. Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).
Woillard JB; Chouchana L; Picard N; Loriot MA;
Therapie; 2017 Apr; 72(2):285-299. PubMed ID: 28318610
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Quaranta S; Thomas F
Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
Quaranta S; Dupouey J; Colle R; Verstuyft C
Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
[TBL] [Abstract][Full Text] [Related]
4. Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.
Zhao W; Fakhoury M; Jacqz-Aigrain E
Ther Drug Monit; 2010 Dec; 32(6):688-99. PubMed ID: 21068645
[TBL] [Abstract][Full Text] [Related]
5. Practicability of pharmacogenetics in transplantation medicine.
van Gelder T; van Schaik RH; Hesselink DA
Clin Pharmacol Ther; 2014 Mar; 95(3):262-4. PubMed ID: 23995265
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
[TBL] [Abstract][Full Text] [Related]
7. Update on the clinical pharmacogenomics of organ transplantation.
Burckart GJ; Amur S
Pharmacogenomics; 2010 Feb; 11(2):227-36. PubMed ID: 20136361
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and immunosuppressive drugs.
Hronová K; Šíma M; Světlík S; Matoušková O; Slanař O
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):821-35. PubMed ID: 25301406
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).
Lamoureux F; Duflot T;
Therapie; 2017 Apr; 72(2):257-267. PubMed ID: 28237404
[TBL] [Abstract][Full Text] [Related]
10. Genetic factors for individual administration of immunosuppressants in organ transplantation.
Yu SF; Wu LH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):337-44. PubMed ID: 16911928
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.
Cattaneo D; Baldelli S; Perico N
Am J Transplant; 2008 Jul; 8(7):1374-83. PubMed ID: 18510642
[TBL] [Abstract][Full Text] [Related]
12. Use of pharmacogenetics to optimize immunosuppressive therapy.
Macphee IA
Ther Drug Monit; 2010 Jun; 32(3):261-4. PubMed ID: 20431509
[TBL] [Abstract][Full Text] [Related]
13. The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.
Picard N; Marquet P
Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):731-43. PubMed ID: 21434840
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics in the treatment of inflammatory bowel disease.
Smith MA; Marinaki AM; Sanderson JD
Pharmacogenomics; 2010 Mar; 11(3):421-37. PubMed ID: 20235796
[TBL] [Abstract][Full Text] [Related]
15. [Effect of genetic polymorphism on disposition of calcineurin inhibitors in solid organ transplantation].
Li D; Zhu L; Ye Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):1018-22. PubMed ID: 20871172
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.
Anglicheau D; Legendre C; Beaune P; Thervet E
Pharmacogenomics; 2007 Jul; 8(7):835-49. PubMed ID: 18240909
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.
Szekeres T; Haushofer A
Pharmacogenomics; 2005 Mar; 6(2):163-8. PubMed ID: 15882134
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of mycophenolate mofetil: a promising different approach to tailoring immunosuppression?
Betonico GN; Abudd-Filho M; Goloni-Bertollo EM; Pavarino-Bertelli E
J Nephrol; 2008; 21(4):503-9. PubMed ID: 18651539
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.
Kurzawski M; Droździk M
Pharmacogenomics; 2013 Jul; 14(9):1099-118. PubMed ID: 23837483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
